The European Research Council (ERC) has awarded RESIST researcher Professor Dr. Yang Li with an ERC Starting Grant – a funding of about 1.5 million Euros over a period of five years. The scientist is director of the Centre for Individualised Infection Medicine (CiiM), a joint institution of the Helmholtz Centre for Infection Research (HZI) and the Hannover Medical School (MHH).

Professor Li analyses why the effectiveness of vaccines differs from person to person. With the ERC-funded project “ModVaccine” she now wants to find out to what extent the effectiveness of a vaccine depends on genetic and non-genetic characteristics of a person as well as on environmental influences. In addition, the individual response to vaccinations will be investigated systematically. “The results of our research will enable to create reliable models for efficacy prediction of vaccines and to develop adapted personalised vaccination strategies against infections,” says Professor Li.

Text source: Homepage of the Helmholtz Centre for Infection Research (HZI).

The proposal has been highlighted at ERC website: https://erc.europa.eu/news-events/magazine/erc-starting-grant-2020-examples

Further information about the research of Professor Dr. Yang Li: https://www.helmholtz-hzi.de/de/forschung/forschungsschwerpunkte/immunantwort-und-interventionen/computational-biology-for-individualised-medicine/yang-li/#anchorsection

Further information on ERC Starting Grants: https://erc.europa.eu/funding/starting-grants

More information about our research